nitrates has been researched along with Alcohol Drinking in 17 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
Alcohol Drinking: Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pain is associated with ipsilateral autonomic symptoms (most commonly lacrimation, conjunctival injection, nasal congestion or rhinorrhea, ptosis, edema of the eyelid, sweating of the forehead or face, and miosis) and a sense of agitation or restlessness." | 2.82 | Cluster Headache: Rapid Evidence Review. ( Bailey, J; Hawks, MK; Malu, OO, 2022) |
| "This paper concerns the medical treatment of heart failure according to the recommendations of the European Society of Cardiology." | 2.44 | [Medical treatment of chronic heart failure]. ( Schüpfer, CA, 2007) |
| "Hypertension is a well-known risk factor for RVO." | 1.62 | Hypertension as a risk factor for retinal vein occlusion in menopausal women: A nationwide Korean population-based study. ( Bae, EH; Choi, HS; Han, KD; Kim, CS; Kim, SW; Ma, SK; Oh, TR, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 4 (23.53) | 2.80 |
| Authors | Studies |
|---|---|
| Kaviani, A | 1 |
| Khansari Nejad, N | 1 |
| Akour, A | 1 |
| AlMuhaissen, SA | 1 |
| Nusair, MB | 1 |
| Al-Tammemi, AB | 1 |
| Mahmoud, NN | 1 |
| Jalouqa, S | 1 |
| Alrawashdeh, MN | 1 |
| Shanahan, JP | 1 |
| Moore, CM | 1 |
| Kampf, JW | 1 |
| Szymczak, NK | 1 |
| Guo, J | 1 |
| Wang, H | 1 |
| Luo, Y | 2 |
| An, H | 1 |
| Zhang, Z | 2 |
| Liu, G | 1 |
| Li, J | 3 |
| Metcalfe, GD | 1 |
| Smith, TW | 1 |
| Hippler, M | 1 |
| Ayala Izurieta, JE | 1 |
| Márquez, CO | 1 |
| García, VJ | 1 |
| Jara Santillán, CA | 1 |
| Sisti, JM | 1 |
| Pasqualotto, N | 1 |
| Van Wittenberghe, S | 1 |
| Delegido, J | 1 |
| Kubo, Y | 1 |
| Kitagawa, Y | 1 |
| Miyazaki, T | 1 |
| Sohda, M | 1 |
| Yamaji, T | 1 |
| Sakai, M | 1 |
| Saeki, H | 1 |
| Nemoto, K | 1 |
| Oyama, T | 2 |
| Muto, M | 1 |
| Takeuchi, H | 1 |
| Toh, Y | 1 |
| Matsubara, H | 1 |
| Mano, M | 1 |
| Kono, K | 1 |
| Kato, K | 2 |
| Yoshida, M | 1 |
| Kawakubo, H | 1 |
| Booka, E | 1 |
| Yamatsuji, T | 1 |
| Kato, H | 1 |
| Ito, Y | 1 |
| Ishikawa, H | 1 |
| Ishihara, R | 1 |
| Tsushima, T | 1 |
| Kawachi, H | 1 |
| Kojima, T | 1 |
| Kuribayashi, S | 1 |
| Makino, T | 1 |
| Matsuda, S | 1 |
| Doki, Y | 1 |
| Ma, P | 1 |
| Tang, X | 1 |
| Zhang, L | 3 |
| Wang, X | 1 |
| Wang, W | 3 |
| Zhang, X | 2 |
| Wang, S | 2 |
| Zhou, N | 1 |
| Dodd, J | 1 |
| Jordan, R | 1 |
| Makhlina, M | 1 |
| Pesco Koplowitz, L | 1 |
| Koplowitz, B | 1 |
| Barnett, K | 1 |
| Yang, WH | 1 |
| Spana, C | 1 |
| Buchanan, SW | 1 |
| Mafa-Attoye, T | 1 |
| Dunfield, K | 1 |
| Thevathasan, NV | 1 |
| Isaac, ME | 1 |
| Wu, X | 2 |
| Huang, JW | 1 |
| Su, BK | 1 |
| Yuan, L | 1 |
| Zheng, WQ | 1 |
| Zhang, H | 3 |
| Zheng, YX | 1 |
| Zhu, W | 1 |
| Chou, PT | 1 |
| Manso, AP | 1 |
| De Morais, DC | 1 |
| Yamamoto, K | 1 |
| Owen, G | 1 |
| de Carvalho, RM | 1 |
| Palma-Dibb, RG | 1 |
| Brown, JC | 1 |
| Yang, S | 1 |
| Mire, EF | 1 |
| Miele, L | 1 |
| Ochoa, A | 1 |
| Zabaleta, J | 1 |
| Katzmarzyk, PT | 1 |
| Moi, CT | 1 |
| Bhowmick, S | 1 |
| Qureshi, M | 1 |
| Wang, K | 1 |
| Feng, B | 1 |
| Yang, Y | 1 |
| Chen, Y | 2 |
| Wang, Y | 3 |
| Yang, L | 1 |
| Jiang, K | 1 |
| James, TD | 1 |
| Chaturvedi, V | 1 |
| Postiglione, WM | 1 |
| Chakraborty, RD | 1 |
| Yu, B | 1 |
| Tabiś, W | 1 |
| Hameed, S | 1 |
| Biniskos, N | 1 |
| Jacobson, A | 1 |
| Zhou, H | 2 |
| Greven, M | 1 |
| Ferry, VE | 1 |
| Leighton, C | 1 |
| Wu, F | 1 |
| Lei, H | 1 |
| Chen, G | 1 |
| Chen, C | 2 |
| Song, Y | 1 |
| Cao, Z | 1 |
| Zhang, C | 2 |
| Zhou, J | 1 |
| Lu, Y | 1 |
| Pappone, C | 1 |
| Santinelli, V | 1 |
| Mecarocci, V | 1 |
| Tondi, L | 1 |
| Ciconte, G | 1 |
| Manguso, F | 1 |
| Sturla, F | 1 |
| Vicedomini, G | 1 |
| Micaglio, E | 1 |
| Anastasia, L | 1 |
| Pica, S | 1 |
| Camporeale, A | 1 |
| Lombardi, M | 1 |
| Shieh, PB | 1 |
| Elfring, G | 1 |
| Trifillis, P | 1 |
| Santos, C | 1 |
| Peltz, SW | 1 |
| Parsons, JA | 1 |
| Apkon, S | 1 |
| Darras, BT | 1 |
| Campbell, C | 1 |
| McDonald, CM | 1 |
| Galaviz, KI | 1 |
| Shah, NS | 1 |
| Gutierrez, M | 1 |
| Collins, LF | 1 |
| Lahiri, CD | 1 |
| Moran, CA | 1 |
| Szabo, B | 1 |
| Sumitani, J | 1 |
| Rhodes, J | 1 |
| Marconi, VC | 1 |
| Nguyen, ML | 1 |
| Cantos, VD | 1 |
| Armstrong, WS | 1 |
| Colasanti, JA | 1 |
| Oh, TR | 1 |
| Han, KD | 1 |
| Choi, HS | 1 |
| Kim, CS | 1 |
| Bae, EH | 1 |
| Ma, SK | 1 |
| Kim, SW | 1 |
| Malu, OO | 1 |
| Bailey, J | 1 |
| Hawks, MK | 1 |
| Qutob, HMH | 1 |
| Saad, RA | 1 |
| Bali, H | 1 |
| Osailan, A | 1 |
| Jaber, J | 1 |
| Alzahrani, E | 1 |
| Alyami, J | 1 |
| Elsayed, H | 1 |
| Alserihi, R | 1 |
| Shaikhomar, OA | 1 |
| Divya, KM | 1 |
| Savitha, DP | 1 |
| Krishna, GA | 1 |
| Dhanya, TM | 1 |
| Mohanan, PV | 1 |
| Shah, SF | 1 |
| Jafry, AT | 1 |
| Hussain, G | 1 |
| Kazim, AH | 1 |
| Ali, M | 1 |
| Rivani, E | 1 |
| Endraswari, PD | 1 |
| Widodo, ADW | 1 |
| Khalil, MR | 1 |
| Guldberg, R | 1 |
| Nørgård, BM | 1 |
| Uldbjerg, N | 1 |
| Wehberg, S | 1 |
| Fowobaje, KR | 1 |
| Mashood, LO | 1 |
| Ekholuenetale, M | 1 |
| Ibidoja, OJ | 1 |
| Romagnoli, A | 1 |
| D'Agostino, M | 1 |
| Pavoni, E | 1 |
| Ardiccioni, C | 1 |
| Motta, S | 1 |
| Crippa, P | 1 |
| Biagetti, G | 1 |
| Notarstefano, V | 1 |
| Rexha, J | 1 |
| Perta, N | 1 |
| Barocci, S | 1 |
| Costabile, BK | 1 |
| Colasurdo, G | 1 |
| Caucci, S | 1 |
| Mencarelli, D | 1 |
| Turchetti, C | 1 |
| Farina, M | 1 |
| Pierantoni, L | 1 |
| La Teana, A | 1 |
| Al Hadi, R | 1 |
| Cicconardi, F | 1 |
| Chinappi, M | 1 |
| Trucchi, E | 1 |
| Mancia, F | 1 |
| Menzo, S | 1 |
| Morozzo Della Rocca, B | 1 |
| D'Annessa, I | 1 |
| Di Marino, D | 1 |
| Choya, A | 1 |
| de Rivas, B | 1 |
| Gutiérrez-Ortiz, JI | 1 |
| López-Fonseca, R | 1 |
| Xu, S | 1 |
| Cheng, B | 1 |
| Huang, Z | 1 |
| Liu, T | 1 |
| Li, Y | 1 |
| Jiang, L | 1 |
| Guo, W | 1 |
| Xiong, J | 1 |
| Amirazodi, M | 1 |
| Daryanoosh, F | 1 |
| Mehrabi, A | 1 |
| Gaeini, A | 1 |
| Koushkie Jahromi, M | 1 |
| Salesi, M | 1 |
| Zarifkar, AH | 1 |
| Studeny, P | 1 |
| Netukova, M | 1 |
| Nemcokova, M | 1 |
| Klimesova, YM | 1 |
| Krizova, D | 1 |
| Kang, H | 1 |
| Tao, Y | 1 |
| Zhang, Q | 1 |
| Sha, D | 1 |
| Yao, J | 1 |
| Gao, Y | 1 |
| Liu, J | 1 |
| Ji, L | 1 |
| Shi, P | 1 |
| Shi, C | 1 |
| Wu, YL | 1 |
| Wright, AI | 1 |
| M El-Metwaly, N | 1 |
| A Katouah, H | 1 |
| El-Desouky, MG | 1 |
| El-Bindary, AA | 1 |
| El-Bindary, MA | 1 |
| Kostakis, ID | 1 |
| Raptis, DA | 1 |
| Davidson, BR | 1 |
| Iype, S | 1 |
| Nasralla, D | 1 |
| Imber, C | 1 |
| Sharma, D | 1 |
| Pissanou, T | 1 |
| Pollok, JM | 1 |
| Hughes, AM | 1 |
| Sanderson, E | 1 |
| Morris, T | 1 |
| Ayorech, Z | 1 |
| Tesli, M | 1 |
| Ask, H | 1 |
| Reichborn-Kjennerud, T | 1 |
| Andreassen, OA | 1 |
| Magnus, P | 1 |
| Helgeland, Ø | 1 |
| Johansson, S | 1 |
| Njølstad, P | 1 |
| Davey Smith, G | 1 |
| Havdahl, A | 1 |
| Howe, LD | 1 |
| Davies, NM | 1 |
| Amrillah, T | 1 |
| Prasetio, A | 1 |
| Supandi, AR | 1 |
| Sidiq, DH | 1 |
| Putra, FS | 1 |
| Nugroho, MA | 1 |
| Salsabilla, Z | 1 |
| Azmi, R | 1 |
| Grammatikopoulos, P | 1 |
| Bouloumis, T | 1 |
| Steinhauer, S | 1 |
| Mironov, VS | 2 |
| Bazhenova, TA | 2 |
| Manakin, YV | 2 |
| Yagubskii, EB | 2 |
| Yakushev, IA | 1 |
| Gilmutdinov, IF | 1 |
| Simonov, SV | 1 |
| Lan, K | 1 |
| Yang, H | 1 |
| Zheng, J | 1 |
| Hu, H | 1 |
| Zhu, T | 1 |
| Zou, X | 1 |
| Hu, B | 1 |
| Liu, H | 1 |
| Olokede, O | 1 |
| Wu, H | 1 |
| Holtzapple, M | 1 |
| Gungor, O | 1 |
| Kose, M | 1 |
| Ghaemi, R | 1 |
| Acker, M | 1 |
| Stosic, A | 1 |
| Jacobs, R | 1 |
| Selvaganapathy, PR | 1 |
| Ludwig, N | 1 |
| Yerneni, SS | 1 |
| Azambuja, JH | 1 |
| Pietrowska, M | 1 |
| Widłak, P | 1 |
| Hinck, CS | 1 |
| Głuszko, A | 1 |
| Szczepański, MJ | 1 |
| Kärmer, T | 1 |
| Kallinger, I | 1 |
| Schulz, D | 1 |
| Bauer, RJ | 1 |
| Spanier, G | 1 |
| Spoerl, S | 1 |
| Meier, JK | 1 |
| Ettl, T | 1 |
| Razzo, BM | 1 |
| Reichert, TE | 1 |
| Hinck, AP | 1 |
| Whiteside, TL | 1 |
| Wei, ZL | 1 |
| Juan, W | 1 |
| Tong, D | 1 |
| Juan, LX | 1 |
| Sa, LY | 1 |
| Jie, HFM | 1 |
| Xiao, G | 1 |
| Xiang, LG | 1 |
| Jie, HM | 1 |
| Xu, C | 1 |
| Yu, DN | 1 |
| Yao, ZX | 1 |
| Bigdeli, F | 1 |
| Gao, XM | 1 |
| Cheng, X | 1 |
| Li, JZ | 1 |
| Zhang, JW | 1 |
| Guan, ZJ | 1 |
| Bu, Y | 1 |
| Liu, KG | 1 |
| Morsali, A | 1 |
| Das, R | 1 |
| Paul, R | 1 |
| Parui, A | 1 |
| Shrotri, A | 1 |
| Atzori, C | 1 |
| Lomachenko, KA | 1 |
| Singh, AK | 1 |
| Mondal, J | 1 |
| Peter, SC | 1 |
| Florimbio, AR | 1 |
| Coughlin, LN | 1 |
| Bauermeister, JA | 1 |
| Young, SD | 1 |
| Zimmerman, MA | 1 |
| Walton, MA | 1 |
| Bonar, EE | 1 |
| Demir, D | 1 |
| Balci, AB | 1 |
| Kahraman, N | 1 |
| Sunbul, SA | 1 |
| Gucu, A | 1 |
| Seker, IB | 1 |
| Badem, S | 1 |
| Yuksel, A | 1 |
| Ozyazicioglu, AF | 1 |
| Goncu, MT | 1 |
| Deng, Z | 1 |
| Luo, L | 1 |
| Ong, SP | 1 |
| Wang, C | 1 |
| Xin, H | 1 |
| Whittingham, MS | 1 |
| Zhou, G | 1 |
| Maemura, R | 1 |
| Wakamatsu, M | 1 |
| Matsumoto, K | 1 |
| Sakaguchi, H | 1 |
| Yoshida, N | 1 |
| Hama, A | 1 |
| Yoshida, T | 1 |
| Miwata, S | 1 |
| Kitazawa, H | 1 |
| Narita, K | 1 |
| Kataoka, S | 1 |
| Ichikawa, D | 1 |
| Hamada, M | 1 |
| Taniguchi, R | 1 |
| Suzuki, K | 1 |
| Kawashima, N | 1 |
| Nishikawa, E | 1 |
| Narita, A | 1 |
| Okuno, Y | 1 |
| Nishio, N | 1 |
| Kojima, S | 1 |
| Morita, K | 1 |
| Muramatsu, H | 1 |
| Takahashi, Y | 1 |
| Yirgu, A | 1 |
| Mekonnen, Y | 1 |
| Eyado, A | 1 |
| Staropoli, A | 1 |
| Vinale, F | 1 |
| Zac, J | 1 |
| Zac, S | 1 |
| Pérez-Padilla, R | 1 |
| Remigio-Luna, A | 1 |
| Guzmán-Boulloud, N | 1 |
| Gochicoa-Rangel, L | 1 |
| Guzmán-Valderrábano, C | 1 |
| Thirión-Romero, I | 1 |
| Statsenko, ME | 1 |
| Turkina, SV | 1 |
| Barantsevich, ER | 1 |
| Karakulova, YV | 1 |
| Baranova, NS | 1 |
| Morzhukhina, MV | 1 |
| Wang, Q | 1 |
| Gu, Y | 1 |
| Qiao, L | 1 |
| Pan, F | 1 |
| Song, C | 1 |
| Canetto, SS | 1 |
| Entilli, L | 1 |
| Cerbo, I | 1 |
| Cipolletta, S | 1 |
| Wu, Y | 2 |
| Zhu, P | 1 |
| Jiang, Y | 1 |
| Wang, Z | 1 |
| Xie, B | 1 |
| Song, T | 1 |
| Zhang, F | 1 |
| Luo, A | 1 |
| Li, S | 1 |
| Xiong, X | 1 |
| Han, J | 1 |
| Peng, X | 1 |
| Li, M | 1 |
| Huang, L | 1 |
| Chen, Q | 1 |
| Fang, W | 1 |
| Hou, Y | 1 |
| Zhu, Y | 1 |
| Ye, J | 1 |
| Liu, L | 1 |
| Islam, MR | 1 |
| Sanderson, P | 1 |
| Johansen, MP | 1 |
| Payne, TE | 1 |
| Naidu, R | 1 |
| Cao, J | 1 |
| Yang, J | 1 |
| Niu, X | 1 |
| Liu, X | 1 |
| Zhai, Y | 1 |
| Qiang, C | 1 |
| Niu, Y | 1 |
| Li, Z | 1 |
| Dong, N | 1 |
| Wen, B | 1 |
| Ouyang, Z | 1 |
| Zhang, Y | 1 |
| Zhao, M | 1 |
| Zhao, J | 1 |
| Morici, P | 1 |
| Rizzato, C | 1 |
| Ghelardi, E | 1 |
| Rossolini, GM | 1 |
| Lupetti, A | 1 |
| Gözüküçük, R | 1 |
| Cakiroglu, B | 1 |
| He, X | 1 |
| Li, R | 1 |
| Zhao, D | 1 |
| Ji, X | 1 |
| Fan, X | 1 |
| Chen, J | 1 |
| Zheng, D | 1 |
| Xie, L | 1 |
| Sun, S | 1 |
| Cai, Z | 1 |
| Liu, Q | 1 |
| Ma, K | 1 |
| Sun, X | 1 |
| Drinkwater, JJ | 1 |
| Davis, TME | 1 |
| Turner, AW | 1 |
| Davis, WA | 1 |
| Suzuki, Y | 1 |
| Mizuta, Y | 1 |
| Mikagi, A | 1 |
| Misawa-Suzuki, T | 1 |
| Tsuchido, Y | 1 |
| Sugaya, T | 1 |
| Hashimoto, T | 1 |
| Ema, K | 1 |
| Hayashita, T | 1 |
| Santos, GM | 1 |
| Coffin, PO | 1 |
| Das, M | 1 |
| Matheson, T | 1 |
| DeMicco, E | 1 |
| Raiford, JL | 1 |
| Vittinghoff, E | 1 |
| Dilley, JW | 1 |
| Colfax, G | 1 |
| Herbst, JH | 1 |
| Baptista, Rde F | 1 |
| Taipeiro, Ede F | 1 |
| Queiroz, RH | 2 |
| Chies, AB | 1 |
| Cordellini, S | 1 |
| Underwood, B | 1 |
| Fox, K | 1 |
| Manogue, M | 1 |
| Perković, O | 1 |
| Jurjević, A | 1 |
| Rudez, J | 1 |
| Antoncić, I | 1 |
| Bralić, M | 1 |
| Kapović, M | 1 |
| Tirapelli, LF | 1 |
| Martins-Oliveira, A | 1 |
| Batalhão, ME | 1 |
| Tirapelli, DP | 1 |
| Carnio, EC | 1 |
| Tanus-Santos, JE | 1 |
| Padovan, CM | 1 |
| Tirapelli, CR | 1 |
| Ostojić, JN | 1 |
| Mladenović, D | 1 |
| Ninković, M | 1 |
| Vučević, D | 1 |
| Bondžić, K | 1 |
| Ješić-Vukićević, R | 1 |
| Radosavljević, T | 1 |
| Schüpfer, CA | 1 |
| Boeing, H | 1 |
| Schlehofer, B | 1 |
| Blettner, M | 1 |
| Wahrendorf, J | 1 |
| Robins, AG | 1 |
| Dew, MA | 1 |
| Kingsley, LA | 1 |
| Becker, JT | 1 |
| Sanz Anquela, JM | 1 |
| Ruiz Liso, JM | 1 |
| Milligan, JR | 1 |
| Zucker, PF | 1 |
| Swann, PF | 1 |
| Archer, MC | 1 |
| Choi, BC | 1 |
| Morikawa, Y | 1 |
| Matsuzaka, J | 1 |
| Kuratsune, M | 1 |
| Tsukamoto, S | 1 |
| Makisumi, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment With Lorcaserin for Cocaine Use: The TLC Study[NCT03192995] | Phase 2 | 22 participants (Actual) | Interventional | 2018-01-01 | Terminated (stopped due to FDA alert regarding study drug safety) | ||
| Reducing HIV Risk Among Episodic Substance Using Men Who Have Sex With Men (SUMSM): Adaptation of the Personalized Cognitive Counseling (PCC) Intervention[NCT01279044] | Phase 1/Phase 2 | 385 participants (Actual) | Interventional | 2007-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
To evaluate the adherence of lorcaserin vs. placebo, the investigators measured adherence as the frequency of taking the study drug as measured by the number of MEMS cap openings (wireless medication monitoring devices that record each opening as a real-time medication event). Cumulative percent adherence was calculated by dividing the frequency of openings at a given time point divided by the number of days since baseline. (NCT03192995)
Timeframe: 12 weeks
| Intervention | percent adherence (Mean) |
|---|---|
| Experimental | 51.6 |
| Control | 66.2 |
To determine the feasibility of retaining individuals on lorcaserin vs. placebo, the investigators have calculated the mean weekly percentage of follow-up visits of those randomized in the study (NCT03192995)
Timeframe: 12 weeks
| Intervention | mean percent of visit retention (Mean) | |
|---|---|---|
| Treatment Group | Control Group | |
| Mean Percent of Weekly Follow-up Visits by Treatment and Control Arms | 83 | 81 |
The outcome measure determines the proportion of self-reported past week cocaine use by Time-Line-Follow-back (TLFB) among lorcaserin and placebo groups at Baseline and at 12 weeks. (NCT03192995)
Timeframe: 12 weeks
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Proportion of self-reported weekly cocaine use by Time-Line-Follow-Up (TLFU) at baseline | Proportion of self-reported weekly cocaine use by TLFU at Week 12 | |
| Control | 6 | 6 |
| Experimental | 12 | 7 |
The outcome measure determines the proportion of urine-positive samples with cocaine positivity among lorcaserin and placebo groups at Baseline and at Week 12 (NCT03192995)
Timeframe: Week 12
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Urine positive samples with cocaine use at baseline | Urine positive samples with cocaine use at Week 12 | |
| Control | 0 | 1 |
| Treatment | 8 | 7 |
"The outcome measure data shows the rate of change in the mean value of the number of condom-protected anal intercourse (UAI) events. Behaviors were self-reported at each study visit using during the past 3 months as the recall period. Study visits took place at baseline, 3 month, and 6 month timepoints.~Serodiscordant defined as having partner of discordant or of unknown HIV serostatus." (NCT01279044)
Timeframe: Self-reported behavior during past 3 months
| Intervention | Self reported behavior in past 3 months (Number) | |||
|---|---|---|---|---|
| Mean number of events at baseline | Mean number of events at 3 months | Mean number of events at 6 months | Rate of change in mean value of outcome over time | |
| HIV Testing With Adapted Personalized Cognitive Risk-reduction | 3.78 | 1.67 | 2.11 | 0.57 |
| HIV Testing With Information Only | 2.83 | 2.13 | 1.29 | 0.44 |
"The outcome measure data shows the rate of change in the mean value of number of instertive unprotected anal intercourse (UAI) events. Behaviors were self-reported at each study visit using during the past 3 months as the recall period. Study visits took place at baseline, 3 month, and 6 month timepoints." (NCT01279044)
Timeframe: Self-reported behavior during past 3 months
| Intervention | Self reported behavior in past 3 months (Number) | |||
|---|---|---|---|---|
| Mean number of events at baseline | Mean number of events at 3 months | Mean number of events at 6 months | Rate of change in mean value over time | |
| HIV Testing With Adapted Personalized Cognitive Risk-reduction | 2.84 | 2.80 | 1.37 | 0.55 |
| HIV Testing With Information Only | 2.44 | 1.32 | 1.14 | 0.41 |
"The outcome measure data shows the rate of change in the mean value of the number of receptive unprotected anal intercourse (UAI) events. Behaviors were self-reported at each study visit using during the past 3 months as the recall period. Study visits took place at baseline, 3 month, and 6 month timepoints." (NCT01279044)
Timeframe: Self-reported behavior during past 3 months
| Intervention | Self reported behavior in past 3 months (Number) | |||
|---|---|---|---|---|
| Mean number of events at baseline | Mean number of events at 3 months | Mean number of events at 6 months | Rate of change in mean value of outcome over time | |
| HIV Testing With Adapted Personalized Cognitive Risk-reduction | 1.39 | 0.61 | 0.45 | 0.31 |
| HIV Testing With Information Only | 1.48 | 0.73 | 0.82 | 0.53 |
"The outcome measure data shows the rate of change in the mean value of number of serodiscordant unprotected anal intercourse events. Behaviors were self-reported at each study visit using during the past 3 months as the recall period. Study visits took place at baseline, 3 month, and 6 month timepoints.~Serodiscordant defined as having partner of discordant or of unknown HIV serostatus." (NCT01279044)
Timeframe: Self-reported behavior during past 3 months
| Intervention | Events in past 3 months (Number) | |||
|---|---|---|---|---|
| Mean number of events at baseline | Mean number of events at 3 months | Mean number of events at 6 months | Rate of change in mean value of outcome over time | |
| HIV Testing With Adapted Personalized Cognitive Risk-reduction | 1.06 | 0.43 | 0.34 | 0.28 |
| HIV Testing With Information Only | 1.13 | 0.49 | 0.55 | 0.47 |
"The outcome measure data shows the rate of change in the mean value in the number of total unprotected anal intercourse events over time. Behaviors were self-reported at each study visit using during the past 3 months as the recall period. Study visits took place at baseline, 3 month, and 6 month timepoints." (NCT01279044)
Timeframe: Self-reported behavior during past 3 months
| Intervention | Self reported events in past 3 months (Number) | |||
|---|---|---|---|---|
| Mean number at baseline | Mean number at 3 months | Mean number at 6 months | Rate of change in mean value of outcome over time | |
| HIV Testing With Adapted Personalized Cognitive Risk-reduction | 4.23 | 3.41 | 1.83 | 0.47 |
| HIV Testing With Information Only | 3.91 | 2.05 | 1.96 | 0.45 |
"The outcome measure data shows the rate of change in the mean value of total unprotected anal intercourse partners over time. Behaviors were self-reported at each study visit using during the past 3 months as the recall period. Study visits took place at baseline, 3 month, and 6 month timepoints." (NCT01279044)
Timeframe: Self-reported behavior during past 3 months
| Intervention | Partners in past 3 months (Number) | |||
|---|---|---|---|---|
| Mean number of partners at baseline | Mean number of partners at 3 months | Mean number of partners at 6 months | Rate of change in mean value of outcome over time | |
| HIV Testing With Adapted Personalized Cognitive Risk-reduction | 2.71 | 1.54 | 1.27 | 0.46 |
| HIV Testing With Information Only | 2.60 | 1.37 | 1.16 | 0.43 |
"The outcome measure data shows the rate of change in the mean value of total unprotected anal intercourse episodes with three most recent sex partners over time. Behaviors were self-reported at each study visit using during the past 3 months as the recall period. Study visits took place at baseline, 3 month, and 6 month timepoints." (NCT01279044)
Timeframe: Self-reported behavior during past 3 months
| Intervention | Episodes in past 3 months (Number) | |||
|---|---|---|---|---|
| Mean number of episodes at baseline | Mean number of episodes at 3 months | Mean number of episodes at 6 months | Rate of change in mean value of outcome over time | |
| HIV Testing With Adapted Personalized Cognitive Risk-reduction | 1.97 | 1.12 | 0.83 | 0.39 |
| HIV Testing With Information Only | 2.31 | 1.11 | 1.20 | 0.52 |
5 reviews available for nitrates and Alcohol Drinking
| Article | Year |
|---|---|
Topics: Adult; Alcohol Drinking; Ammonia; Animals; Anti-Inflammatory Agents; Area Under Curve; B-Lymphocytes | 2021 |
Cluster Headache: Rapid Evidence Review.
Topics: Adult; Alcohol Drinking; Cluster Headache; Female; Humans; Male; Nitrates; Nitroglycerin; Oxygen; Pa | 2022 |
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter | 2022 |
[Medical treatment of chronic heart failure].
Topics: Adrenergic beta-Antagonists; Alcohol Drinking; Angiotensin-Converting Enzyme Inhibitors; Calcium Cha | 2007 |
[Gastric cancer. I. Epidemiology].
Topics: Aged; Alcohol Drinking; Cooking; Diet; Female; Humans; Male; Middle Aged; Nitrates; Nitrites; Nitros | 1988 |
2 trials available for nitrates and Alcohol Drinking
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter | 2022 |
Plethysmographic study of effects of alcohol.
Topics: Alcohol Drinking; Alcoholic Intoxication; Central Nervous System; Clinical Trials as Topic; Ethanol; | 1968 |
11 other studies available for nitrates and Alcohol Drinking
| Article | Year |
|---|---|
Hypertension as a risk factor for retinal vein occlusion in menopausal women: A nationwide Korean population-based study.
Topics: Adult; Age Factors; Alcohol Drinking; Blood Glucose; Blood Pressure; Cigarette Smoking; Comorbidity; | 2021 |
Dose-response associations between number and frequency of substance use and high-risk sexual behaviors among HIV-negative substance-using men who have sex with men (SUMSM) in San Francisco.
Topics: Adult; Alcohol Drinking; Cocaine; Confidence Intervals; Cross-Sectional Studies; HIV Seronegativity; | 2013 |
Dose-response associations between number and frequency of substance use and high-risk sexual behaviors among HIV-negative substance-using men who have sex with men (SUMSM) in San Francisco.
Topics: Adult; Alcohol Drinking; Cocaine; Confidence Intervals; Cross-Sectional Studies; HIV Seronegativity; | 2013 |
Dose-response associations between number and frequency of substance use and high-risk sexual behaviors among HIV-negative substance-using men who have sex with men (SUMSM) in San Francisco.
Topics: Adult; Alcohol Drinking; Cocaine; Confidence Intervals; Cross-Sectional Studies; HIV Seronegativity; | 2013 |
Dose-response associations between number and frequency of substance use and high-risk sexual behaviors among HIV-negative substance-using men who have sex with men (SUMSM) in San Francisco.
Topics: Adult; Alcohol Drinking; Cocaine; Confidence Intervals; Cross-Sectional Studies; HIV Seronegativity; | 2013 |
Stress alone or associated with ethanol induces prostanoid release in rat aorta via alpha2-Adrenoceptor.
Topics: Alcohol Drinking; Animals; Aorta, Thoracic; Cardiovascular Diseases; Endothelium, Vascular; Ethanol; | 2014 |
Tobacco, alcohol and drug use among dental undergraduates at one English university in 1998 and 2008.
Topics: Alcohol Drinking; Amphetamine-Related Disorders; Anabolic Agents; Cross-Sectional Studies; England; | 2010 |
The town of Cabar, Croatia, a high risk area for multiple sclerosis--analytic epidemiology of dietary factors.
Topics: Alcohol Drinking; Croatia; Dietary Fats; Feeding Behavior; Food; Food Preservation; Fruit; Humans; M | 2010 |
Ethanol consumption increases the expression of endothelial nitric oxide synthase, inducible nitric oxide synthase and metalloproteinases in the rat kidney.
Topics: Alcohol Drinking; Animals; Biomarkers; Ethanol; Kidney; Male; Metalloproteases; Nitrates; Nitric Oxi | 2012 |
The effects of cold-induced stress on liver oxidative injury during binge drinking.
Topics: Alanine Transaminase; Alcohol Drinking; Animals; Antioxidants; Aspartate Aminotransferases; Cold-Sho | 2012 |
Dietary carcinogens and the risk for glioma and meningioma in Germany.
Topics: Alcohol Drinking; Ascorbic Acid; Carcinogens; Case-Control Studies; Diet; Dietary Fats; Germany; Gli | 1993 |
Do homosexual and bisexual men who place others at potential risk for HIV have unique psychological profiles?
Topics: Adaptation, Psychological; Alcohol Drinking; Bisexuality; Cohort Studies; Health Education; Health K | 1997 |
Absence of urinary N-nitrosodimethylamine in fasting humans following alcohol consumption.
Topics: Adult; Alcohol Drinking; Aminopyrine; Biotransformation; Dimethylnitrosamine; Fasting; Humans; Male; | 1987 |
N-Nitroso compounds and human cancer. A molecular epidemiologic approach.
Topics: Adult; Alcohol Drinking; Brain Neoplasms; Chemical Phenomena; Chemistry; Diet; Dimethylnitrosamine; | 1985 |